Specifically, between 1 and 7 weeks of age, control hearts experienced a highly significant decrease in cardiac output (100 ± 8 nL min −1 vs. 21 ± 2 nL min −1 ) (Fig. 2 B).
← all excerpts
Modest overexpression of FOXO maintains cardiac proteostasis and ameliorates age-associated functional decline.
1
—
—